Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.98% | -27.29% | |||
| Total Other Revenue | 8.98% | 23.34% | |||
| Total Revenue | 8.98% | -23.21% | |||
| Cost of Revenue | 8.98% | -4.73% | |||
| Gross Profit | 8.98% | -40.60% | |||
| SG&A Expenses | 8.98% | 4.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.98% | -2.91% | |||
| Operating Income | 8.98% | -54.35% | |||
| Income Before Tax | 8.98% | -64.30% | |||
| Income Tax Expenses | 8.98% | 188.27% | |||
| Earnings from Continuing Operations | 8.98% | -72.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.98% | -72.85% | |||
| EBIT | 8.98% | -54.35% | |||
| EBITDA | 8.98% | -54.42% | |||
| EPS Basic | 8.98% | -73.18% | |||
| Normalized Basic EPS | 8.99% | -64.73% | |||
| EPS Diluted | 8.98% | -70.64% | |||
| Normalized Diluted EPS | 8.98% | -64.20% | |||
| Average Basic Shares Outstanding | 0.00% | 1.22% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||